Condition: Peanut-Induced Anaphylaxis · Peanut Allergy · Sponsor: Ukko Inc
This study will test a new investigational treatment called UKK-0018. UKK-0018 as an immunotherapeutic for the treatment of peanut allergies. The treatment is given by injection and is designed to train the immune system to tolerate peanut exposure over time.
This description comes directly from the study's public registry record.
Clinical Development Officer · +1 503 915 1400 · sharron@ukko.us
Always discuss trial participation with your own doctor first.
| Royal Prince Alfred Hospital | Camperdown, New South Wales, Australia | Not Yet Recruiting |
| Flinders Medical Center | Bedford Park, South Australia, Australia | Not Yet Recruiting |
| The Royal Melbourne Hospital | Fitzroy, Victoria, Australia | Recruiting |
| Fiona Stanley Hospital | Perth, Western Australia, Australia | Not Yet Recruiting |
| Pacific Clinical Research Network - Auckland | Takapuna, Auckland, New Zealand | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07349212